Further investigations to clarify the genetic involvement of HLA-A*26 and its correlation with the particular clinical manifestations of BD phenotypes in the Northeast Asian population might lead to one of the clues to understanding why there are regional disparities of phenotypes within BD patients. This evidence concerns the gene HLA-A and Behcet disease.